These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6930335)

  • 1. Non-specific cross-reacting antigen serum concentration in myeloid leukemias.
    Frénoy N; Burtin P
    Clin Chim Acta; 1980 Apr; 103(1):23-31. PubMed ID: 6930335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of factors influencing serum NCA (non-specific cross-reacting antigen) level in patients with chronic myeloid leukaemia.
    Frénoy N; Ben-Bunant M; Berruel C; Child JA; Gendron MC; Missett JL; Razafimahaleo E; Burtin P
    Br J Cancer; 1982 Nov; 46(5):765-72. PubMed ID: 6756460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of NCA (nonspecific cross-reacting antigen) in the cells of the human granulocyte series.
    Burtin P; Flandrin G; Fondaneche MC
    Blood Cells; 1980; 6(2):263-78. PubMed ID: 6991029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of NCA in patients with chronic myelocytic leukemia.
    Wahren B; Gahrton G; Rudén U; Hammarström S
    Int J Cancer; 1982 Feb; 29(2):133-7. PubMed ID: 6949877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.
    Noworolska A; Harłozińska A; Richter R; Brodzka W
    Br J Cancer; 1985 Mar; 51(3):371-7. PubMed ID: 3882113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects.
    Noworolska A; Harłozińska A; Buchegger F; Lawińska B; Richter R
    Blut; 1989 Feb; 58(2):69-73. PubMed ID: 2920218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of levels of carcinoembryonic antigen and nonspecific cross-reacting antigen in the sera of neonatal infants: brief communication.
    von Kleist S; Troupel S; King M; Burtin P
    J Natl Cancer Inst; 1977 Dec; 59(6):1621-3. PubMed ID: 72823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of surface nonspecific cross-reacting antigen and influence of proteolytic enzymes on this antigen in myeloid cell series.
    Noworolska A; Harłozińska-Szmyrka A; Richter R
    Cancer Detect Prev; 1986; 9(3-4):365-71. PubMed ID: 3527416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed hypersensitivity reactions in patients with acute leukemias and blastic crisis of chronic granulocytic leukemia.
    Frydecka I; Becker M
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):645-7. PubMed ID: 6935989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the CEA gene family members NCA-50/90 and NCA-160 (CD66) in childhood acute lymphoblastic leukemias (ALLs) and in cell lines of B-cell origin.
    Hanenberg H; Baumann M; Quentin I; Nagel G; Grosse-Wilde H; von Kleist S; Göbel U; Burdach S; Grunert F
    Leukemia; 1994 Dec; 8(12):2127-33. PubMed ID: 7808000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Common null antigen of acute lymphoblastic leukemia and "lymphoid" variant of the blastic phase of chronic myeloid leukemia].
    Baryshnikov AIu; Morozova LF; Volkova MA; Frinovskaia IV; Maiakova SA
    Probl Gematol Pereliv Krovi; 1982 Sep; 27(9):23-5. PubMed ID: 6757918
    [No Abstract]   [Full Text] [Related]  

  • 12. Is non-specific cross-reacting antigen a marker on the surface of human basophils?
    Bloch-Morot E; Lebel B; Burtin C; Sabine MC; Burtin P
    Ann Immunol (Paris); 1977; 128(6):979-84. PubMed ID: 74231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in patients with lymphomas and leukemias.
    Patel GV; Gopal R; Nadkarni JJ
    Neoplasma; 1984; 31(2):197-202. PubMed ID: 6585680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Non-specific cross reacting antigen (NCA)", a tracer of human granulocytes and monocytes].
    Burtin P
    C R Seances Soc Biol Fil; 1979; 173(2):261-9. PubMed ID: 92357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic structures of CEA and CEA-related normal antigens and problems related to the determination of blood CEA concentrations].
    Matsuoka Y; Kuroki M; Koga Y
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):575-84. PubMed ID: 6192762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
    Burtin P; Chavanel G; Hendrick JC; Frenoy N
    J Immunol; 1986 Aug; 137(3):839-45. PubMed ID: 2424986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.
    Carpentier NA; Lange GT; Fiere DM; Fournie GJ; Lambert PH; Miescher PA
    J Clin Invest; 1977 Oct; 60(4):874-84. PubMed ID: 268330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigens and circulating immune complexes related to the primate retroviral glycoprotein SiSVgp70. Indicators of early mortality in human acute leukemias and chronic myelogenous leukemias in blast crisis.
    Hehlmann R; Erfle V; Schetters H; Luz A; Rohmer H; Schreiber MA; Pralle H; Essers U; Weber W
    Cancer; 1984 Dec; 54(12):2927-35. PubMed ID: 6093985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.